ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Novartis Announces New Phase 3 Study for Spinal Muscular Atrophy Treatment in Elderly Patients americanpharmaceuticalreview
August 04, 2021Novartis announced that the U.S. FDA determined that OAV-101 intrathecal (IT) clinical trials for spinal muscular atrophy (SMA) patients may proceed, thereby lifting the partial clinical trial hold initiated in October 2019. -
STEER appoints Subodh Jindal as CEO expresspharma
December 17, 2020He will be responsible for business strategy and plant operations for the engineering business with focused attention to fast-emerging fields of pharma continuous manufacturing solutions, plastic recycling solutions, and the food processing industry.
Pharma Sources Insight January 2025
